Table 3 One-year survival and mortality ratios during the first year of follow-up.
From: Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study
One year survival | Unadjusted mortality ratio | Adjusted mortality ratio a | |
Ovarian cancer without VTE (control group) | 63% (62–64%) | ||
Ovarian cancer less than 4 months after VTE | 44% (33–60%) | 1.8 (1.3–2.7) | 1.7 (1.2–2.5) |
Ovarian cancer 4 months to 27 years after VTE | 54% (44–66%) | 1.4 (1.0–1.9) | 1.2 (0.8–1.7) |